See up to 3 months of ANNX. The 7-day demo opens the 1M and 3M ranges and puts ANNX on your watchlist.
Start 7-day demoLatest ANNX insider trades
About Annexon, Inc. (ANNX)
Annexon, Inc. files with the SEC under CIK 0001528115 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
ANNX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 26,065 | $100K |
| Grant or award | 1 | 175,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ANNX insider transactions (Form 4)
3646 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Douglas Love - Officer | Open-market purchase | Common Stock | 26,065 | $3.83 footnote F1 | $100K | |
| ||||||
| Mark S. Blumenkranz - Director | Grant or award | Stock Option (Right to Buy) | 175,000 | $0.00 | - | |
| William D. Waddill | Grant or award | Stock Option (Right to Buy) | 65,000 | $0.00 | - | |
| Muneer A. Satter | Grant or award | Stock Option (Right to Buy) | 65,000 | $0.00 | - | |
| William A. Jones Jr. | Grant or award | Stock Option (Right to Buy) | 65,000 | $0.00 | - | |
| Bettina M. Cockroft | Grant or award | Stock Option (Right to Buy) | 65,000 | $0.00 | - | |
| Jung Choi | Grant or award | Stock Option (Right to Buy) | 65,000 | $0.00 | - | |
| William H. Carson | Grant or award | Stock Option (Right to Buy) | 65,000 | $0.00 | - | |
| Ted Yednock - Officer | Option exercise | Common Stock | 30,646 | $1.85 | $57K | |
| Ted Yednock - Officer | Option exercise | Stock Option (Right to Buy) | 30,646 | $0.00 | - | |
| Muneer A. Satter | Open-market purchase | Common Stock | 613,497 footnote F1 | $5.41 | $3.32M | |
| ||||||
| William H. Carson | Open-market purchase | Common Stock | 8,000 | $5.78 | $46K | |
| William H. Carson | Open-market purchase | Common Stock | 8,000 | $6.20 | $50K | |
| William H. Carson | Open-market purchase | Common Stock | 8,000 | $5.67 | $45K | |
 Jamie Dananberg - Officer | Open-market sale | Common Stock | 5,820 | $5.43 footnote F2 | $32K | |
| ||||||
| Michael Overdorf - Officer | Open-market sale | Common Stock | 4,339 | $5.42 footnote F2 | $24K | |
| ||||||
| Ted Yednock - Officer | Open-market sale | Common Stock | 5,566 | $5.42 footnote F2 | $30K | |
| ||||||
| Dean Richard Artis - Officer | Open-market sale | Common Stock | 5,894 | $5.43 footnote F2 | $32K | |
| ||||||
 Jennifer Lew - Officer | Open-market sale | Common Stock | 5,565 | $5.42 footnote F2 | $30K | |
| ||||||
| Douglas Love - Officer | Grant or award | Stock Option (Right to Buy) | 1,250,000 | $0.00 | - | |
| Jamie Dananberg - Officer | Grant or award | Common Stock | 56,250 footnote F1 | $0.00 | - | |
| Jamie Dananberg - Officer | Grant or award | Stock Option (Right to Buy) | 225,000 | $0.00 | - | |
| ||||||
| Michael Overdorf - Officer | Grant or award | Common Stock | 62,500 footnote F1 | $0.00 | - | |
| Michael Overdorf - Officer | Grant or award | Stock Option (Right to Buy) | 250,000 | $0.00 | - | |
| ||||||
| Dean Richard Artis - Officer | Grant or award | Common Stock | 62,500 footnote F1 | $0.00 | - | |
| Dean Richard Artis - Officer | Grant or award | Stock Option (Right to Buy) | 250,000 | $0.00 | - | |
| ||||||
| Ted Yednock - Officer | Grant or award | Common Stock | 62,500 footnote F1 | $0.00 | - | |
| Ted Yednock - Officer | Grant or award | Stock Option (Right to Buy) | 250,000 | $0.00 | - | |
| ||||||
| Jennifer Lew - Officer | Grant or award | Common Stock | 62,500 footnote F1 | $0.00 | - | |
| Jennifer Lew - Officer | Grant or award | Stock Option (Right to Buy) | 250,000 | $0.00 | - | |
| ||||||
| Jamie Dananberg - Officer | Open-market sale | Common Stock | 5,290 | $5.10 footnote F2 | $27K | |
| ||||||
| Jennifer Lew - Officer | Open-market sale | Common Stock | 7,851 | $5.11 footnote F2 | $40K | |
| ||||||
| Dean Richard Artis - Officer | Open-market sale | Common Stock | 5,290 | $5.10 footnote F2 | $27K | |
| ||||||
| Ted Yednock - Officer | Open-market sale | Common Stock | 7,857 | $5.11 footnote F2 | $40K | |
| ||||||
| Michael Overdorf - Officer | Open-market sale | Common Stock | 6,225 | $5.10 footnote F2 | $32K | |
| ||||||
| William H. Carson | Open-market purchase | Common Stock | 4,115 | $4.47 footnote F2 | $18K | |
| ||||||
Item 2.02, 8.01, 9.01
Item 5.02, 7.01, 9.01
Item 8.01, 9.01
Item 1.01, 2.03, 8.01, 9.01
Recent ANNX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| WIGGANS THOMAS G | Former Director | 2,000 | $11K | View on EDGAR | |
| - | - | - | - |
ANNX insider trading FAQ
What is the latest insider trade for ANNX?
Annexon, Inc. (ANNX) had 2 insider filings in the last 90 days, with the most recent on 2026-09-25. The full record for ANNX runs to 46 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ANNX stock?
1 insider purchase of ANNX was filed in the last 90 days, totaling $100K.
How many insiders are selling ANNX stock?
No insider sales of ANNX were filed in the last 90 days. 14 sales are on record for this company.
Where can I see ANNX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ANNX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Douglas Love view on EDGAR
- - Mark S. Blumenkranz view on EDGAR
- - William D. Waddill view on EDGAR
- - Muneer A. Satter view on EDGAR
- - William A. Jones Jr. view on EDGAR
- - Bettina M. Cockroft view on EDGAR
- - Jung Choi view on EDGAR
- - William H. Carson view on EDGAR
- - Ted Yednock view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ANNX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ANNX with a 7-day demo
- ANNX on your watchlist
- Every ANNX Form 4 filing on record
- Up to 3 months of ANNX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
